Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing NaN - NaN of 91
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Baltimore (biological, drug, other)

Recruiting
  • Multiple Myeloma
  • GM-CSF vaccine
  • +4 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 6, 2022

Multiple Myeloma Trial in Worldwide (Selinexor, Bortezomib, Dexamethasone)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Plantation, Florida
  • +156 more
Nov 23, 2021

Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in United States (oprozomib)

Terminated
  • Multiple Myeloma
  • Waldenstrom Macroglobulinemia
  • Scottsdale, Arizona
  • +18 more
Nov 15, 2021

Multiple Myeloma Trial in United States (Ixazomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +32 more
Oct 8, 2021

Subjects Treated With ACTR T Cell Product

Terminated
  • B Cell Lymphomas
  • +3 more
  • ACTR T Cell Product
  • Gilbert, Arizona
  • +15 more
Oct 4, 2021

Cytogenetic Studies in Acute Leukemia and Multiple Myeloma

Active, not recruiting
  • Acute Leukemia
  • +3 more
  • cytogenetic analysis
  • La Jolla, California
  • +136 more
Aug 16, 2021

Multiple Myeloma Trial in Worldwide (Durvalumab, Pomalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Little Rock, Arkansas
  • +34 more
Aug 4, 2021

Multiple Myeloma Trial in United States (zoledronic acid)

Completed
Has Results
  • Multiple Myeloma
  • zoledronic acid
  • Casa Grande, Arizona
  • +41 more
May 3, 2021

Multiple Myeloma Trial in Baltimore (biological, drug, procedure)

Completed
Has Results
  • Multiple Myeloma
  • Activated marrow infiltrating lymphocytes
  • +6 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 16, 2021

Multiple Myeloma Trial in United States (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Daratumumab, Lenalidomide)

Completed
  • Multiple Myeloma
  • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
  • +4 more
  • Birmingham, Alabama
  • +30 more
Mar 31, 2021

Multiple Myeloma Trial in Baltimore (aMIL, No aMIL)

Completed
Has Results
  • Multiple Myeloma
  • aMIL
  • No aMIL
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jun 11, 2020

Cancer, Hematologic Malignancies, Multiple Myeloma Trial in Worldwide (Denosumab, Zoledronic acid, Placebo to Denosumab)

Completed
Has Results
  • Cancer
  • +5 more
  • Tucson, Arizona
  • +308 more
Mar 19, 2020

Multiple Myeloma Trial in Worldwide (Panobinostat, Bortezomib, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Phoenix, Arizona
  • +209 more
Mar 8, 2020

Multiple Myeloma Trial in United States (PCI-32765, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • La Jolla, California
  • +10 more
Mar 2, 2020

Bone Marrow Transplantation, Hematopoietic Stem Cells, Multiple Myeloma Trial in Baltimore (Neupogen, Hyperbaric oxygen therapy,

Withdrawn
  • Bone Marrow Transplantation
  • +3 more
  • Baltimore, Maryland
    University of Maryland Medical Center
Dec 9, 2019

Multiple Myeloma Trial in Baltimore, Philadelphia (Autologous Genetically modified T cells)

Completed
Has Results
  • Multiple Myeloma
  • Autologous Genetically modified T cells
  • Baltimore, Maryland
  • +1 more
Nov 19, 2019

Multiple Myeloma Trial in Canada, United States (Pomalidomide)

Approved for marketing
  • Multiple Myeloma
  • Duarte, California
  • +41 more
Nov 7, 2019

Multiple Myeloma Trial in United States (CC-5013)

Completed
  • Multiple Myeloma
  • Glendale, Arizona
  • +25 more
Nov 7, 2019

Peripheral Neuropathies, Multiple Myeloma Trial in Baltimore (Acupuncture)

Completed
Has Results
  • Peripheral Neuropathies
  • Multiple Myeloma
  • Acupuncture
  • Baltimore, Maryland
    University of Maryland Marlene & Stewart Greenebaum Cancer Cente
Nov 5, 2019

Multiple Myeloma Trial in Baltimore (MK-3475, Pomalidomide, Dexamethasone)

Terminated
Has Results
  • Multiple Myeloma
  • Baltimore, Maryland
    Greenebaum Cancer Center at University of Maryland Medical Cente
Nov 1, 2019

Multiple Myeloma Trial in Baltimore, Philadelphia (hTERT vaccine, GM-CSF, PCV, T cell infusion, GM-CSF, PCV, T cell infusion)

Completed
  • Multiple Myeloma
  • hTERT vaccine, GM-CSF, PCV, T cell infusion
  • GM-CSF, PCV, T cell infusion
  • Baltimore, Maryland
  • +1 more
Oct 21, 2019

Multiple Myeloma, Advanced Solid Tumors Trial in Canada, United States (Ixazomib)

Completed
Has Results
  • Multiple Myeloma
  • Advanced Solid Tumors
  • Atlanta, Georgia
  • +10 more
Mar 8, 2019

Multiple Myeloma Trial in Worldwide (Daratumumab)

Approved for marketing
  • Multiple Myeloma
  • Phoenix, Arizona
  • +78 more
Jan 11, 2019

Multiple Myeloma Trial in Baltimore (Lenalidomide, Allogeneic Myeloma Vaccine, Prevnar-13)

Completed
Has Results
  • Multiple Myeloma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 14, 2019

Multiple Myeloma Trial in Baltimore (MEDI-551 Maintenance)

Terminated
Has Results
  • Multiple Myeloma
  • MEDI-551 Maintenance
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 10, 2019